IL23A and Arthritis: We further silenced IL-23p19 in mice with CIA by administering intraperitoneal injections of LVshIL-23p19 and observed lower arthritis scores than those in mice receiving LVshLuc, serving as the control vector, and medium-treated control mice (Figure 1B).